Search
for
Sort by
Research 61–90 of 306
- Chemotherapy-induced alopecia
- Intelligent nanotherapeutic strategies for the delivery of CRISPR system
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions
- LHX2: a transcription factor in development, homeostasis, repair, and disease
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Enhancing Cancer Therapy with Hyperthermia: Synergistic Effects with Natural Compounds and Conventional Treatments
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- Identification of key genes induced by platelet-rich plasma in human dermal papilla cells using bioinformatics methods
- Overexpression of hepatoma-derived growth factor in melanocytes does not lead to oncogenic transformation
- Stem Cell Competition for Niche Occupancy: Emerging Themes and Mechanisms
- Cutaneous extramedullary haematopoiesis: Implications in human disease and treatment
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- Hematopoietic Stem Cells: Nature and Niche Nurture
- Primary cutaneous diffuse large B‑cell lymphoma of the scalp: A case report and brief review of the literature
- Platelet-rich plasma promotes cell viability of human hair dermal papilla cells (HHDPCs) in vitro.
- The role of prolactin in the reactivation of hair follicles in relation to moulting in cashmere goats
- TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia
- Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy
- Canine and Feline Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease?
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Aggressive treatment in paediatric or young patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) is associated with future development of type III polyglandular autoimmune syndrome
- Temporal lobe epilepsy exacerbation during pharmacological inhibition of endogenous neurosteroid synthesis
- Biotinidase deficiency – clinching the diagnosis rapidly can make all the difference!
- Ban Tu Wan hepatotoxicity
- Rapid hair depigmentation in patient treated with pazopanib
- Gefitinib-induced hair alterations: Figure 1
- Androgenic alopecia: an entity to consider in adolescence
- Virilising ovarian tumour in a woman with an adrenal nodule
- Ashwagandha root in the treatment of non-classical adrenal hyperplasia